166 related articles for article (PubMed ID: 6994769)
1. Acute and chronic renal effects of guanfacine in essential and renal hypertension.
Roeckel A; Heidland A
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):141S-149S. PubMed ID: 6994769
[TBL] [Abstract][Full Text] [Related]
2. [Central hypotensive effects of guanfacine in anaesthetised rabbits (author's transl)].
Ohkubo K; Suzuki K; Oguma M; Otorii T
Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):263-74. PubMed ID: 7047324
[TBL] [Abstract][Full Text] [Related]
3. [Antihypertensive effect of guanfacine in rats].
Nakagawa Y; Takeda K; Hashimoto T; Sakurai H; Mitomi A; Imai S; Hamamura M; Kumada M
Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):295-312. PubMed ID: 6762984
[TBL] [Abstract][Full Text] [Related]
4. The influence of renal function on plasma concentration, urinary excretion and antihypertensive effect of guanfacine.
Kirch W; Köhler H; Braun W; von Gizycki C
Clin Pharmacokinet; 1980; 5(5):476-83. PubMed ID: 6996890
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamics in hypertensive patients before and during guanfacine treatment.
Schäfer N; Rauh J; Rosenthal J
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
[TBL] [Abstract][Full Text] [Related]
6. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
Schoeppe W; Brecht HM
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
[TBL] [Abstract][Full Text] [Related]
7. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
Rosenthal J; Schäfer N; Rauh J; Raschig A
Dtsch Med Wochenschr; 1980 Nov; 105(48):1680-4. PubMed ID: 7002524
[TBL] [Abstract][Full Text] [Related]
8. Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
Ikeda T; Gomi T; Yuhara M; Sakurai J; Nakayama D
Clin Pharmacol Ther; 1988 Mar; 43(3):278-82. PubMed ID: 3278821
[TBL] [Abstract][Full Text] [Related]
9. Peripheral effects of guanfacine compared to those of clonidine in the dog.
Hashimoto K; Nakagawa Y; Hashimoto T; Tsukada T; Takeda K; Imai S
Jpn Circ J; 1980 Nov; 44(11):883-92. PubMed ID: 6253699
[TBL] [Abstract][Full Text] [Related]
10. Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs.
Salzmann R; Gerber W; Pally C; Scholtysik G
J Pharm Pharmacol; 1983 May; 35(5):293-8. PubMed ID: 6134797
[TBL] [Abstract][Full Text] [Related]
11. Comparative haemodynamic effects of clonidine and guanfacine.
Oates HF; Stoker LM; MacCarthy EP; Monaghan JC; Stokes GS
Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):148-56. PubMed ID: 565192
[TBL] [Abstract][Full Text] [Related]
12. Studies on clonidine and guanfacine withdrawal after short term treatment in the rat.
Barber ND; Reid JL
Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):112-8. PubMed ID: 6758716
[TBL] [Abstract][Full Text] [Related]
13. The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats.
Salzmann R
J Pharm Pharmacol; 1979 Apr; 31(4):212-6. PubMed ID: 36458
[TBL] [Abstract][Full Text] [Related]
14. Elimination of guanfacine in patients with normal and impaired renal function.
Kirch W; Köhler H; Braun W
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):33S-35S. PubMed ID: 6994776
[TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of guanfacine and clonidine on blood pressure, heart rate, urinary catecholamines, and cyclic nucleotides during and after administration to patients with mild to moderate hypertension.
Nami R; Bianchini C; Fiorella G; Chierichetti SM; Gennari C
J Cardiovasc Pharmacol; 1983; 5(4):546-51. PubMed ID: 6193349
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
Manhem P; Hökfelt B
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
[No Abstract] [Full Text] [Related]
17. [Guanfacinum (BS 100-14) in long-term therapy of severe hypertension].
Röckel A; Sabel B; Heidland A
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():314-8. PubMed ID: 347805
[No Abstract] [Full Text] [Related]
18. Acute action of guanfacine on peripheral circulation in hypertensive patients: measurements of arterial flow of the calf and of the forefoot, of venous capacity of the calf, of the blood pressure and of the heart rate.
Ehringer H; Berger G; Ingerle H; Konecny U; Wöss A
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):115S-121S. PubMed ID: 6994764
[TBL] [Abstract][Full Text] [Related]
19. Guanfacine and clonidine: antihypertensive and withdrawal characteristics after continuous infusion and its interruption in the spontaneously hypertensive and normotensive rat.
Thoolen MJ; Timmermans PB; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):82-6. PubMed ID: 7050735
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of guanfacine.
Scholtysik G
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):21S-24S. PubMed ID: 6249333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
